Drug Shortage Report for RECOMBIVAX HB
Report ID | 175542 |
Drug Identification Number | 02243676 |
Brand name | RECOMBIVAX HB |
Common or Proper name | (hepatitis B vaccine [recombinant]) |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 10MCG |
Dosage form(s) | SUSPENSION SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10MCG/1ML 1DOSE VIAL |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-12-02 |
Actual start date | 2022-12-01 |
Estimated end date | 2023-05-12 |
Actual end date | 2023-05-11 |
Shortage status | Resolved |
Updated date | 2023-05-12 |
Company comments | Remaining doses are reserved for the public immunization program. Limited quantities available for private orders. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-11-24 | English | Compare |
v2 | 2022-11-24 | English | Compare |
v3 | 2022-11-24 | French | Compare |
v4 | 2022-11-25 | English | Compare |
v5 | 2022-11-28 | English | Compare |
v6 | 2022-11-28 | French | Compare |
v7 | 2022-11-28 | English | Compare |
v8 | 2022-11-28 | French | Compare |
v9 | 2022-12-01 | English | Compare |
v10 | 2022-12-01 | French | Compare |
v11 | 2022-12-02 | English | Compare |
v12 | 2022-12-14 | English | Compare |
v13 | 2022-12-14 | French | Compare |
v14 | 2022-12-14 | English | Compare |
v15 | 2022-12-14 | French | Compare |
v16 | 2023-02-27 | English | Compare |
v17 | 2023-02-27 | French | Compare |
v18 | 2023-05-11 | English | Compare |
v19 | 2023-05-11 | French | Compare |
v20 | 2023-05-12 | English | Compare |
Showing 1 to 20 of 20